← Leaderboards
Wassim W Labaki
University Of Michigan At Ann Arbor
$874,800
Attributed
$874,800
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $175K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$874,800 · 1
By mechanism
K23$874,800 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Charles F Burant$27,360,950
- Ling-Jian Meng$8,122,409
- Meilan K Han$16,787,558
- Gary B. Huffnagle$14,751,708
- Craig J Galban$12,293,457
Others in their field
Other Emerging Leaders on “Disease Heterogeneity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Kathleen Maletic Neuzil · Emory University$26,552,931
- George Robert Painter · University Of Alabama At Birmingham$25,957,440
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$16,767,001
Research focus
Disease HeterogeneityAccountingCostAmino AcidsAwardAffectBioinformaticsAchievementBiometryBody CompositionBody SystemCachexiaCareer DevelopmentCause Of DeathCellsChronic BronchitisBiologicalAftercareClinical PhenotypeClinical ResearchClinical TrialsCohortComplementDisease Phenotype
Grant awards (5)
Leveraging Serum Metabolomics to Understand Clinical Phenotypes in COPD$174,960
K23 · FY2024 · HL · contact PI
Leveraging Serum Metabolomics to Understand Clinical Phenotypes in COPD$174,960
K23 · FY2023 · HL · contact PI
Leveraging Serum Metabolomics to Understand Clinical Phenotypes in COPD$174,960
K23 · FY2022 · HL · contact PI
Leveraging Serum Metabolomics to Understand Clinical Phenotypes in COPD$174,960
K23 · FY2021 · HL · contact PI
Leveraging Serum Metabolomics to Understand Clinical Phenotypes in COPD$174,960
K23 · FY2020 · HL · contact PI